Rephonic
Artwork for Gastrointestinal Cancer Update

Gastrointestinal Cancer Update

Dr. Neil Love
Biliary Tract Cancers
Immunotherapy
Gastroesophageal Cancer
Hepatobiliary Cancers
Immune Checkpoint Inhibitors
Clinical Trials
Targeted Therapy
Cholangiocarcinoma
Hepatocellular Carcinoma
Gastroesophageal Cancers
HER2
Colorectal Cancer
Emerald 1 Study
Adjuvant Therapy
Circulating Tumor DNA
Hypercalcemia
FGFR Inhibitors
Locoregional Therapy
Patient Care
Neuroendocrine Tumors

This series bridges the gap between research and patient care by providing medical oncologists and hematologists with ongoing access to the perspectives and opinions of national and international clinical investigators with expertise in gastrointestinal cancers.

PublishesTwice monthlyEpisodes322Founded20 years ago
Number of ListenersCategories
MedicineHealth & FitnessScience

Listen to this Podcast

Artwork for Gastrointestinal Cancer Update

Latest Episodes

Dr Jaffer Ajani from The University of Texas MD Anderson Cancer Center in Houston, Dr Rutika Mehta from Weill Cornell Medicine/NewYork-Presbyterian Hospital in New York, New York, Dr John Strickler from Duke University in Durham, North Carolina, and ... more

Dr Haley Ellis from Harvard Medical School in Boston, Massachusetts, Prof Eric Van Cutsem from University Hospitals Leuven in Belgium, Dr Zev Wainberg from UCLA School of Medicine in Los Angeles, California, and moderator Dr Lionel KankeuFonkoua from... more

Dr Scott Kopetz from The University of Texas MD Anderson Cancer Center in Houston discusses recent developments with circulating tumor DNA assays in the management of colorectal cancer.

CME information and select publications here.

Dr Scott Kopetz from The University of Texas MD Anderson Cancer Center in Houston discusses recent developments with circulating tumor DNA assays in the management of colorectal cancer.

CME information and select publications here.

Key Facts

Accepts Guests
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

NEJM This Week
NEJM This WeekNEJM Group
ASCO Daily News
ASCO Daily NewsAmerican Society of Clinical Oncology (ASCO)

Recent Guests

Bikai Saab
Discussed findings from recent colorectal cancer studies
Episode: Colorectal Cancer — 5-Minute Journal Club Issue 2 with Dr Scott Kopetz: Current and Future Role of Tumor-Informed Circulating Tumor DNA Assays
Dr. Jonathan Strosberg
Expert in neuroendocrine cancers and medical oncologist at Moffitt Cancer Center
Moffitt Cancer Center
Episode: Extrapulmonary Neuroendocrine Carcinoma — An Interview with Dr Jonathan Strosberg on Current and Future Management
Dr. Paul Overstein
Medical oncologist at Perlmutter Comprehensive Cancer Center
Perlmutter Comprehensive Cancer Center
Episode: Pancreatic Cancer — Fourth Annual National General Medical Oncology Summit
Dr. Philip Philip
Oncologist at Henry Ford Cancer Center
Henry Ford Cancer Center
Episode: Pancreatic Cancer — Fourth Annual National General Medical Oncology Summit
Ghassan Abu Alpha
Clinical investigator at Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Episode: Hepatocellular Carcinoma — Proceedings From a Session Held in Conjunction with the 2025 ASCO Gastrointestinal Cancers Symposium (ASCO GI)
Thomas Abrams
Clinical investigator at Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Episode: Hepatocellular Carcinoma — Proceedings From a Session Held in Conjunction with the 2025 ASCO Gastrointestinal Cancers Symposium (ASCO GI)
Dr. Pam Kunz
Oncologist from the Yale School of Medicine
Yale Cancer Center
Episode: Inside the Issue: Optimizing the Diagnosis and Treatment of Neuroendocrine Tumors
Dr. Simron Singh
Oncologist from the University of Toronto
Odette Cancer Center, Sunnybrook Health Sciences Centre
Episode: Inside the Issue: Optimizing the Diagnosis and Treatment of Neuroendocrine Tumors
Mrinal Gounder
Medical Oncologist at Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Episode: Oncology Today with Dr Neil Love: Optimizing the Management of Dedifferentiated Liposarcoma

Host

Dr. Neil Love
Medical oncologist and host, known for bridging the gap between clinical practice and the latest research findings in oncology.

Reviews

4.3 out of 5 stars from 23 ratings
  • Gastrointestinal Cancers

    Podcast Addict
    5
    Donald Gravenor
    6 years ago

Top Science Podcasts

Something You Should Know
Something You Should KnowMike Carruthers | OmniCast Media
Hidden Brain
Hidden BrainHidden Brain, Shankar Vedantam
Radiolab
RadiolabWNYC Studios
StarTalk Radio
StarTalk RadioNeil deGrasse Tyson
Science Friday
Science FridayScience Friday and WNYC Studios
Big Ideas Lab
Big Ideas LabMission.org
Sasquatch Chronicles
Sasquatch ChroniclesSasquatch Chronicles - Bigfoot Encounters

Talking Points

Recent interactions between the hosts and their guests.

Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancers — Proceedings from a Session Held Adjunct to the 2026 ASCO Gastrointestinal Cancers Symposium
Q: What about the toxicity component?
Diarrhea is a significant toxicity but is manageable, and we have learned to manage it effectively in the clinic.
Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancers — Proceedings from a Session Held Adjunct to the 2026 ASCO Gastrointestinal Cancers Symposium
Q: So what's your sort of top line impression of the data?
Based on the evidence, Xanadatamab belongs in the treatment algorithm for a patient with HER2-positive advanced gastroesophageal cancer.
Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancers — Proceedings from a Session Held Adjunct to the 2026 ASCO Gastrointestinal Cancers Symposium
Q: If all of this stuff was available to you right now, what would you do clinically?
So I would ensure the patient can tolerate the immune options, and I would give all three drugs, which include Xanadetamab, Tislaelusamab, and chemotherapy.
Advanced Gastroesophageal Cancers — Expert Perspectives on Actual Patient Cases: Part 2 of 2
Q: What would be the recommendations for second line therapy upon progression?
TDXD would probably be a good option; starting it earlier in the disease course is generally preferred.
HER2-Positive Gastrointestinal Cancers — Proceedings from a Session Held During the 2025 ASCO Annual Meeting
Q: So Dr. Ellis, this is an issue now with this particular patient in this case, but it's this idea of reassessing her status after a patient like Dr. Lonardi's patient has already received anti-HER2 therapy?
I think reassessing biomarker status with comprehensive molecular profiling is really important at the time of progression to determine resistance causes.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About Gastrointestinal Cancer Update

What is Gastrointestinal Cancer Update about and what kind of topics does it cover?

Focused on the complexities of gastrointestinal cancers, the series features expert insights from oncologists and clinical investigators who address the latest research and treatment advancements. Episodes consistently explore emerging therapies, clinical trials, and the implications of recent findings in various gastrointestinal cancers including colorectal, biliary tract, and neuroendocrine cancers. The series highlights significant case studies that illustrate patient management strategies and therapeutic decision-making, sharing knowledge on everything from molecular residual disease analysis to the role of immunotherapy. This unique consortium of expert opinions helps keep healthcare professionals informed on best practices and evolvin... more

Where can I find podcast stats for Gastrointestinal Cancer Update?

Rephonic provides a wide range of podcast stats for Gastrointestinal Cancer Update. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to Gastrointestinal Cancer Update and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does Gastrointestinal Cancer Update get?

Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for Gastrointestinal Cancer Update, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for Gastrointestinal Cancer Update?

Rephonic provides comprehensive predictive audience data for Gastrointestinal Cancer Update, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does Gastrointestinal Cancer Update have?

To see how many followers or subscribers Gastrointestinal Cancer Update has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to Gastrointestinal Cancer Update?

These podcasts share a similar audience with Gastrointestinal Cancer Update:

1. Breast Cancer Update
2. Prostate Cancer Update
3. Gynecologic Oncology Update
4. NEJM This Week
5. ASCO Daily News

How many episodes of Gastrointestinal Cancer Update are there?

Gastrointestinal Cancer Update launched 20 years ago and published 322 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact Gastrointestinal Cancer Update?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for Gastrointestinal Cancer Update?

Rephonic pulls ratings and reviews for Gastrointestinal Cancer Update from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for Gastrointestinal Cancer Update?

Rephonic provides full transcripts for episodes of Gastrointestinal Cancer Update. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on Gastrointestinal Cancer Update?

Recent guests on Gastrointestinal Cancer Update include:

1. Bikai Saab
2. Dr. Jonathan Strosberg
3. Dr. Paul Overstein
4. Dr. Philip Philip
5. Ghassan Abu Alpha
6. Thomas Abrams
7. Dr. Pam Kunz
8. Dr. Simron Singh

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days